REPL Stock: Price, Earnings History and SEC Filings
Replimune Group, Inc. (REPL) last traded at $17.61, up 1.27% on the latest session and up 33.0% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $-0.54 against an analyst estimate of $-0.70, a beat of 22.9%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
REPL earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $-0.54 | $-0.70 | +22.86% |
| Jun 2026 | Aug 14, 2026 | $-0.72 | $-0.72 | +0.00% |
| Mar 2026 | Jun 29, 2026 | $-0.76 | $-0.73 | -4.11% |
| Dec 2025 | Feb 3, 2026 | $-0.77 | $-0.85 | +9.41% |
REPL beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How REPL reacts to earnings
Across its last 8 earnings releases, REPL moved 5.8% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | Before open | +23.07% |
| 2026-08-14 | Before open | -1.45% |
| 2026-06-29 | Before open | -3.70% |
| 2026-02-03 | Before open | +5.81% |
| 2025-11-06 | Before open | -0.93% |
| 2025-08-07 | Before open | -0.36% |
| 2025-05-22 | Before open | +3.55% |
| 2025-02-12 | Before open | +7.32% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
Latest SEC filings for REPL
- 10-Q · Oct 28, 2026
- 8-K · Oct 28, 2026Results of operations, Financial statements and exhibits
- 8-K · Sep 16, 2026Bylaw change, Shareholder vote, Financial statements and exhibits
- 10-Q · Aug 14, 2026
- 8-K · Aug 14, 2026Results of operations, Financial statements and exhibits
- 8-K · Aug 10, 2026Other events, Financial statements and exhibits
- 424B5 · Aug 10, 2026
- 8-K · Aug 7, 2026Other events, Financial statements and exhibits
- 8-K · Jul 31, 2026Other events, Financial statements and exhibits
- 8-K · Jul 30, 2026Regulation FD disclosure, Financial statements and exhibits
Insider filing activity
REPL insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
REPL news
- Replimune Soars 17% as TUDRIQEV Melanoma Launch Draws “Enthusiastic” Response From PhysiciansOct 29, 2026 · tikr.com
- Why Did ETSY, REPL, GMAB Stocks Surge To 52-Week Highs Today?Oct 29, 2026 · stocktwits.com
- Is Replimune Group (REPL) Cheap Following Its Reduced Net Loss Results?Oct 29, 2026 · finance.yahoo.com
- Replimune: 3 Key Takeaways for Long-Term InvestorsOct 29, 2026 · fool.com
- Replimune Group, Inc. Q2 2027 Earnings Call SummaryOct 29, 2026 · app.moby.co
- Replimune (REPL) Q2 2027 Earnings Call TranscriptOct 28, 2026 · fool.com
- Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate UpdateOct 28, 2026 · finance.yahoo.com
- Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026Oct 22, 2026 · finance.yahoo.com
About Replimune Group, Inc.
Replimune Group, Inc. (REPL) is a US-listed public company on Nasdaq. The SEC classifies its business as Biological Products (no Diagnostic Substances). It is incorporated in DE. Its fiscal year ends in March.